ICT BIO 2008 - Combining the Power of ICT with Biomedical Sciences

Major diseases like cancer, neurological and cardiovascular diseases are complex in nature involving environmental, life style, ageing and genetic components. One of the future challenges is to integrate the knowledge of all these different components into robust and fully reliable computer models and "in silico" environments that will help the development and testing of new therapies for better prediction and prevention tools in healthcare.

An integrative research approach is therefore required to better understand the complex mechanisms behind human diseases. In this approach, all processes that occur at multiple levels from molecules to cells, organs and organisms are seen not as separate events but as parts of a multi-scale system which aims at improving the understanding of the human health and diseases.

To face this challenge a new generation of multidisciplinary science fields is emerging at the crossroads of Information Technology, Medicine and Biology that provide "in silico" multi-scale modeling and simulation in medicine and biology. For example, patient-specific computer models of human cells or organs can bring new understanding of disease, support discovery of new drugs or can help visualising the effects of different choices of treatments.

To realise this ambitious vision at the crossroads of Information and Communication Technologies and Biomedical Sciences, researchers from different disciplines must work together on virtually everything that can be observed and measured at multiple biological levels in relation to human physiological diseases. The European Commission is investing in this topic through complementary research programmes in Information and Communication Technologies and Health research.

The Directorate-General Information Society and Media (DG INFSO) supports this integrative research through funding of projects in the area of multi-scale modeling and simulation known as the "Virtual Physiological Human" (VPH) initiative. The Directorate-General Research (DG RTD) supports through funding of projects in the areas of health research and systems biology.

The conference will take place over two days (Oct. 23-24). Each day will start with a plenary session featuring high-level policy speakers including EU Commissioners, Member of Parliaments, prominent scientists and international funding agency representatives from the EU, US and beyond.

In the afternoon, parallel sessions will focus on themes incorporating ICT and life sciences such as multi-scale modeling in cancer research, heart and cardiovascular diseases, muscular-skeleton systems, and ageing. The conference website is updated regularly with the latest information on the sessions and exhibition.

Media events (press-conference, press release, demos to media) will communicate to non-specialists the importance of the synergy between ICT, Biomedical Sciences and Health research and the concrete benefits for all citizens in terms of better healthcare.

During both days an exhibition will be held at the conference venue showcasing amongst others 3D medical imaging and prototypes, interactive audiovisual and technical demonstrations. These demos will be exhibited by on-going research projects showing concrete results in this multidisciplinary research field. The exhibition will be a great opportunity for the public to see the applications of the latest technologies and new tools that will help the development of novel therapies for a more predictive and preventive healthcare.

The Conference is free of charge and online registration is compulsory, entrance will not be permitted without the confirmation letter.

Please note that as the number of seats in the meeting rooms is limited, the Commission reserves the right to confirm, on a free selection basis, only as many registrations as seats available. The confirmation of attendance letter will be sent at the latest on 15th September.

Have Your Say
Logged-in site visitors are able to use the site's 'Comment' function to show their interest in or comment on the event in one of two ways:

  • suggest a contribution - your idea will be forwarded to the session coordinator. If successful, you will be able to develop it further by adding documents;
  • comment on a session - relevant questions and comments will be communicated to the chairman of the session and potentially addressed during the session.

Alongside the conference, the 1st Transatlantic Workshop on Multiscale Cancer Modelling will take place at the same venue.

Computational and mathematical cancer modelling is already a driving force behind interdisciplinary cancer systems biology. Understanding cancer as a complex dynamic bio system requires finding ways to investigate and ultimately target its many constituents and their dynamic relationships across multiple scales in space and time - i.e., multi-scale modelling and simulation. Geared towards translation into clinical practice, long term goals of these modelling approaches include supporting patient specific treatment optimization.

In recognizing the significant contribution of teams on both sides of the Atlantic to this emergent field of in silico oncology, the US National Cancer Institute and the European Commission jointly support a workshop that is being co-organized by NCI’s Center for the Development of a Virtual Tumor, CViT, and EC's Advancing Clinico Genomics Trials Program, ACGT.

This workshop aims to present cutting edge approaches, to demonstrate the field's potential and to discuss common challenges it faces in moving forward. The ideal outcome is facilitated interaction between the teams, increased visibility of the achievements beyond the nascent community and formulation of a shared vision that can be advanced into joint funding programs.

The following modelling and simulation topics will be addressed: carcinogenesis, prevascular and vascular progression, invasion and metastasis, tumour growth across spatiotemporal scales and clinically oriented tumour modelling. All major multilevel approaches i.e. bottom-up, top-down and middle-out will be delineated through carefully selected paradigms. Initiatives regarding translation of multiscale cancer models into the arena of clinical trials will be outlined and their potential will be discussed.

Programme is available at the ICT BIO conference website under the Transatlantic Workshop button.

For further information and registration, please visit:
http://ec.europa.eu/information_society/
events/ict_bio/2008/index_en.htm

Related news articles:

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...